Chemoinformaics analysis of Dimethyl tetrasulfide
| Molecular Weight | 158.338 | nRot | 3 |
| Heavy Atom Molecular Weight | 152.29 | nRig | 0 |
| Exact Molecular Weight | 157.935 | nRing | 0 |
| Solubility: LogS | -4.583 | nHRing | 0 |
| Solubility: LogP | 0.987 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 12 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 18.9408 |
| nHD | 0 | BPOL | 8.47924 |
| QED | 0.457 |
| Synth | 4.687 |
| Natural Product Likeliness | 1.312 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.003 |
| HIA | 0.019 |
| CACO-2 | -4.827 |
| MDCK | 0.0000215 |
| BBB | 0.841 |
| PPB | 0.282113 |
| VDSS | 1.007 |
| FU | 0.568431 |
| CYP1A2-inh | 0.942 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.982 |
| CYP2c19-sub | 0.872 |
| CYP2c9-inh | 0.86 |
| CYP2c9-sub | 0.656 |
| CYP2d6-inh | 0.089 |
| CYP2d6-sub | 0.491 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.318 |
| CL | 9.917 |
| T12 | 0.146 |
| hERG | 0.352 |
| Ames | 0.276 |
| ROA | 0.833 |
| SkinSen | 0.961 |
| Carcinogencity | 0.229 |
| EI | 0.996 |
| Respiratory | 0.99 |
| NR-Aromatase | 0.096 |
| Antiviral | No |
| Prediction | 0.989 |